CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 36 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,000 | +180.0% | 2,650 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | 0.0% | 2,650 | +15.9% | 0.00% | – |
| Q2 2016 | $5,000 | 0.0% | 2,287 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -28.6% | 2,287 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | -30.0% | 2,287 | 0.0% | 0.00% | – |
| Q3 2015 | $10,000 | -16.7% | 2,287 | 0.0% | 0.00% | – |
| Q2 2015 | $12,000 | 0.0% | 2,287 | +40.0% | 0.00% | – |
| Q1 2015 | $12,000 | +9.1% | 1,633 | 0.0% | 0.00% | – |
| Q4 2014 | $11,000 | 0.0% | 1,633 | -7.3% | 0.00% | – |
| Q3 2014 | $11,000 | -26.7% | 1,761 | +8.4% | 0.00% | – |
| Q2 2014 | $15,000 | -89.6% | 1,625 | -90.8% | 0.00% | – |
| Q1 2014 | $144,000 | +39.8% | 17,700 | +10.3% | 0.00% | – |
| Q4 2013 | $103,000 | +9.6% | 16,042 | +70.8% | 0.00% | – |
| Q3 2013 | $94,000 | – | 9,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |